GlobeNewswire 21/10 Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt...
GlobeNewswire 21/10 AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene ...
GlobeNewswire 21/10 New TransUnion Research Reveals Marketers’ Confidence in Measurement Has Stalled
GlobeNewswire 20/10 Invest in Bogotá Strengthens the City’s Regional Leadership in the Shared Services Industry
GlobeNewswire 20/10 ST introduces new image sensors for industrial automation, security and retail applications
GlobeNewswire 17/10 Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Sq...
GlobeNewswire 16/10 Building a Resilient Agrifood System: 2025 World Agrifood Innovation Conference Opens in Beijing
GlobeNewswire 16/10 AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Direc...
GlobeNewswire 15/10 Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and ...
GlobeNewswire 14/10 Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
GlobeNewswire 12/10 DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements i...
GlobeNewswire 10/10 AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in ...
GlobeNewswire 08/10 Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatme...
GlobeNewswire 06/10 Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date...
TeleTrader 06/10 Europe opens mostly lower ahead of data
GlobeNewswire 03/10 Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
GlobeNewswire 02/10 AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meetin...
GlobeNewswire 30/09 Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kama...
GlobeNewswire 26/09 Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old...
GlobeNewswire 25/09 BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
GlobeNewswire 24/09 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire 24/09 BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
GlobeNewswire 22/09 First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson...
GlobeNewswire 22/09 First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational c...
GlobeNewswire 22/09 Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU...